Iovance Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
CEOFrederick G. Vogt
CEOFrederick G. Vogt
Employees838
Employees838
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2007
Founded2007
Employees838
Employees838
IOVA Key Statistics
Market cap577.71M
Market cap577.71M
Price-Earnings ratio-1.41
Price-Earnings ratio-1.41
Dividend yield—
Dividend yield—
Average volume10.38M
Average volume10.38M
High today$1.82
High today$1.82
Low today$1.67
Low today$1.67
Open price$1.72
Open price$1.72
Volume9.32M
Volume9.32M
52 Week high$12.51
52 Week high$12.51
52 Week low$1.64
52 Week low$1.64
IOVA News
Simply Wall St 5d
Iovance Biotherapeutics (NasdaqGM:IOVA) Announces CFO Resignationrecently experienced executive change, with CFO Jean-Marc Bellemin announcing his resignation effective July 10, 2025, following his June 10 decision to pursue...
Analyst ratings
67%
of 12 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.